Report Overview

Indian Endometriosis Drugs Market size was valued at USD XX billion in 2019 and is expected to expand at a compound annual growth rate (CAGR) of XX% from 2019 to 2028.

Endometriosis is a disorder in which tissue as the one that develops in the uterus's lining develops outside of the uterine cavity. Endometrium is the lining of uterus. One of the mentionable factor propelling the market growth is the rising occurrence rate of infertility among women. Approximately 40% of women with infertility are detected with endometriosis. Inflammation associated with endometriosis may result in damaging the egg or sperm or interfere with their movement through the uterus and fallopian tubes. Severe cases of endometriosis which may result in blockage of the fallopian tubes by scar tissue or adhesions. The condition can be managed by surgical options and medication, which are effective in the management of potential complications associated with the disease and its symptoms.



Market Drivers

Growing prevalence of endometriosis that has also lead in higher awareness among the women related to endometriosis treatment. With significant rise in the occurrence of this disease, investment in research and development are also increased expanding growth opportunity in this market. With this large number of women facing endometriosis, huge developments are taking place in endometriosis treatment by including advanced technologies. Significant efforts are being made in the improving the diagnosis methods, as there is a high demand for endometriosis treatment. Most importantly, women across the nation are now more aware about their condition and vocal about it that makes the growth in this market highly lucrative and important.